| Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma M Went, A Sud, A Försti, BM Halvarsson, N Weinhold, S Kimber, ... Nature communications 9 (1), 3707, 2018 | 110 | 2018 |
| Genetic predisposition for multiple myeloma M Pertesi, M Went, M Hansson, K Hemminki, RS Houlston, B Nilsson Leukemia 34 (3), 697-708, 2020 | 41 | 2020 |
| Search for multiple myeloma risk factors using Mendelian randomization M Went, AJ Cornish, PJ Law, B Kinnersley, M van Duin, N Weinhold, ... Blood advances 4 (10), 2172-2179, 2020 | 32 | 2020 |
| Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9 AF Schmidt, MV Holmes, D Preiss, DI Swerdlow, S Denaxas, G Fatemifar, ... BMC cardiovascular disorders 19, 1-10, 2019 | 30 | 2019 |
| Genetic predisposition to multiple myeloma at 5q15 is mediated by an ELL2 enhancer polymorphism N Li, DC Johnson, N Weinhold, S Kimber, SE Dobbins, JS Mitchell, ... Cell reports 20 (11), 2556-2564, 2017 | 23 | 2017 |
| Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology M Went, A Sud, H Speedy, NJ Sunter, A Försti, PJ Law, DC Johnson, ... Blood cancer journal 9 (1), 1, 2018 | 18 | 2018 |
| Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes M Went, B Kinnersley, A Sud, DC Johnson, N Weinhold, A Försti, ... Human genomics 13, 1-8, 2019 | 17 | 2019 |
| Functional dissection of inherited non-coding variation influencing multiple myeloma risk R Ajore, A Niroula, M Pertesi, C Cafaro, M Thodberg, M Went, EL Bao, ... nature communications 13 (1), 151, 2022 | 15 | 2022 |
| A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25. 3 and 3p22. 1: a LOC Network study K Labreche, M Daniau, A Sud, PJ Law, L Royer-Perron, A Holroyd, ... Neuro-oncology 21 (8), 1039-1048, 2019 | 14 | 2019 |
| Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach M Went, A Sud, PJ Law, DC Johnson, N Weinhold, A Försti, M van Duin, ... Blood cancer journal 7 (6), e573-e573, 2017 | 13 | 2017 |
| Germline variants at SOHLH2 influence multiple myeloma risk L Duran-Lozano, G Thorleifsson, A Lopez de Lapuente Portilla, A Niroula, ... Blood Cancer Journal 11 (4), 76, 2021 | 8 | 2021 |
| Genetically proxied ketohexokinase function and risk of colorectal cancer: a Mendelian randomisation study AM Buziau, PJ Law, G Blokland, C Schalkwijk, J Scheijen, P Simons, ... Gut 72 (3), 604-606, 2023 | 4 | 2023 |
| Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma M Went, A Sud, A Försti, BM Halvarsson, N Weinhold, S Kimber, ... Nature Communications 10 (1), 213, 2019 | 2 | 2019 |
| Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controls M Went, A Sud, C Mills, A Hyde, R Culliford, P Law, J Vijayakrishnan, ... medRxiv, 2023 | 1 | 2023 |
| Deciphering genetic susceptibility to multiple myeloma M Went Institute of Cancer Research (University Of London), 2020 | 1 | 2020 |
| Regions of homozygosity as risk factors for multiple myeloma M Went, A Sud, N Li, DC Johnson, JS Mitchell, M Kaiser, RS Houlston Annals of human genetics 83 (4), 231-238, 2019 | 1 | 2019 |
| Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers M Went, A Sud, C Mills, A Hyde, R Culliford, P Law, J Vijayakrishnan, ... Nature Communications 15 (1), 2637, 2024 | | 2024 |
| Exploiting gene dependency to inform drug development for multiple myeloma M Went, PH Hoang, PJ Law, MF Kaiser, RS Houlston Scientific Reports 12 (1), 12696, 2022 | | 2022 |
| The clinical utility of polygenic risk scores for multiple myeloma A Sud, M Went, P Law, M Kaiser, R Houlston Springer Nature [academic journals on nature. com], 2022 | | 2022 |
| Author Correction: Germline variants at SOHLH2 influence multiple myeloma risk L Duran-Lozano, G Thorleifsson, A Lopez de Lapuente Portilla, A Niroula, ... Blood Cancer Journal 11 (11), 181, 2021 | | 2021 |
Richard HoulstonThe Institute of Cancer ResearchVerified email at icr.ac.uk
